Neuren Pharmaceuticals | NEU - Equity Capital And Reserves

Stock Price
13.00
Daily Change
0.70 5.69%
Monthly
11.30%
Yearly
49.08%
Q2 Forecast
11.77

Neuren Pharmaceuticals reported AUD338.45M in Equity Capital and Reserves for its fiscal semester ending in December of 2025.





Equity Capital And Reserves Change Date
Akebia Therapeutics USD 32.61M 8.98M Dec/2025
Alaunos Therapeutics USD 2.8M 858K Sep/2025
Avita Medical AUD -16.65M 3.76M Dec/2025
Clinuvel Pharmaceuticals AUD 249.02M 8.21M Dec/2025
Dianthus Therapeutics USD 493.4M 53.05M Dec/2025
Genetic Signatures AUD 44.09M 6M Dec/2025
Ionis Pharmaceuticals USD 617.97M 13.76M Sep/2025
Medical Developments International AUD 54.77M 335K Dec/2025
Neuren Pharmaceuticals AUD 338.45M 15.18M Dec/2025
Organon & Co USD 906M 173M Sep/2025
Paradigm Biopharmaceuticals AUD 6M 15.18M Dec/2025
PYC Therapeutics AUD 147.18M 22.82M Dec/2025
Starpharma Holdings AUD 21.48M 2.48M Dec/2025
Tectonic Therapeutic USD 251.33M 16.2M Dec/2025
Telix Pharmaceuticals AUD 416.86M 5.08M Dec/2025
Viatris USD 15.22B 352.9M Sep/2025
Xeris Pharmaceuticals USD 13.69M 14.55M Dec/2025